| Literature DB >> 31026591 |
Aisha Yesbolatova1, Toyoaki Natsume1, Ken-Ichiro Hayashi2, Masato T Kanemaki3.
Abstract
Controlling protein expression using a degron is advantageous because the protein of interest can be rapidly depleted in a reversible manner. We pioneered the development of the auxin-inducible degron (AID) technology by transplanting a plant-specific degradation pathway to non-plant cells. In human cells expressing an E3 ligase component, OsTIR1, it is possible to degrade a degron-fused protein with a half-life of 15-45 min in the presence of the phytohormone auxin. We reported previously the generation of human HCT116 mutants in which the C terminus of endogenous proteins was fused with the degron by CRISPR-Cas9-based knock-in. Here, we show new plasmids for N-terminal tagging and describe a detailed protocol for the generation of AID mutants of human HCT116 and DLD1 cells. Moreover, we report the use of an OsTIR1 inhibitor, auxinole, to suppress leaky degradation of degron-fused proteins. The addition of auxinole is also useful for rapid re-expression after depletion of degron-fused proteins. These improvements enhance the utility of AID technology for studying protein function in living human cells.Entities:
Keywords: Auxin; Conditional mutant; Degradation inhibitor; Degron; Genome editing; Protein degradation
Mesh:
Substances:
Year: 2019 PMID: 31026591 DOI: 10.1016/j.ymeth.2019.04.010
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608